Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
The latest announcement is out from Fevertree Drinks ( (GB:FEVR) ).
Fevertree Drinks PLC announced the repurchase of 28,000 of its own ordinary shares, as part of a buyback program initiated earlier in the year. The shares were bought at prices ranging from 771 to 795 pence, with a weighted average price of 782.3074 pence. This move is intended to cancel the purchased shares, potentially impacting the company’s stock value and shareholder equity by reducing the number of shares available in the market.
The most recent analyst rating on (GB:FEVR) stock is a Hold with a £921.00 price target. To see the full list of analyst forecasts on Fevertree Drinks stock, see the GB:FEVR Stock Forecast page.
Spark’s Take on GB:FEVR Stock
According to Spark, TipRanks’ AI Analyst, GB:FEVR is a Neutral.
Fevertree Drinks’ strong financial performance, characterized by robust cash flow and a healthy balance sheet, is the primary driver of its stock score. Technical analysis indicates a neutral trend with some bullish momentum, while valuation concerns due to a high P/E ratio slightly offset the positives. The absence of earnings call data and corporate events means these factors do not influence the score.
To see Spark’s full report on GB:FEVR stock, click here.
More about Fevertree Drinks
Fevertree Drinks PLC is a company operating in the beverage industry, known for its premium mixers, including tonic waters, ginger ales, and other carbonated drinks. The company focuses on providing high-quality mixers that complement premium spirits, catering to a market that values quality and taste.
Average Trading Volume: 478,312
Technical Sentiment Signal: Strong Sell
Current Market Cap: £924.4M
Find detailed analytics on FEVR stock on TipRanks’ Stock Analysis page.

